Evidence for tissue-directed immune responses: Analysis of CD4- and CD8-dependent alloimmunity

Transplantation

Volumn 78, Issue 8, 2004, Pages 1125-1133

  Lunsford, Keri E ^a,b   Gao, Donghong ^b   Eiring, Anna M ^b   Wang, Yue ^b   Frankel, Wendy L ^b   Bumgardner, Ginny L ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

CD4+ and CD8+ T cells; Hepatocytes; Islets; Transgenic knockout; Transplantation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MONOCLONAL ANTIBODY;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN DETECTION; ARTICLE; CELL TRANSPLANTATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GENETIC SUSCEPTIBILITY; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KNOCKOUT MOUSE; LIVER CELL; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOZOCIN DIABETES; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD4; ANTIGENS, CD8; DISEASE SUSCEPTIBILITY; GRAFT REJECTION; HEPATOCYTES; IMMUNITY; IMMUNOSUPPRESSION; ISLETS OF LANGERHANS TRANSPLANTATION; ISOANTIGENS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, SCID; TRANSPLANTATION, HOMOLOGOUS;

EID: 7044229428     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000138098.19429.99     Document Type: Article

References (50)

1. Orosz CG, Wakely E, Bergese SD, et al. Prevention of murine cardiac allograft rejection with gallium nitrate. Comparison with anti-CD4 monoclonal antibody. Transplantation 1996; 61(5): 783.
2. Pearson TC, Darby CR, Bushell AR, et al. The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation 1993; 55(2): 361.
3. + cells are essential for allorejection. J Exp Med 1996; 184: 2013.
4. Rashid A, Auchincloss HJ, Sharon J. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice. J Immunol 1992; 148(5): 1382.
5. + cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts. Transplantation 1997; 63(8): 1123.
6. + T cells. Transplantation 1992; 54(2): 278.
7. + cells in islet allograft rejection. Transplantation 1990; 50(1): 120.
8. + T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression. Cell Transplant 1996; 5(5): 525.
9. + T cell in allograft rejection. J Immunol 1987; 139(12): 4022.
10. Shizuru JA, Gregory AK, Chao CT-B, et al. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Science 1987; 237: 278.
11. + T cell dependent. J Immunol 1999; 162(5): 2503.
12. Gill RG, Rosenberg AS, Lafferty KJ, et al. Characterization of primary T cell subsets mediating rejection of pancreatic islet grafts. J Immunol 1989; 143(7): 2176.
13. Bumgardner GL, Gao D, Li J, et al. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4 KO, and CD8 KO mice. Transplantation 2000; 70(12): 1771.
14. + T-cell responses in acute rejection. Transplantation 1999; 68(4): 555.
15. + T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. Transplantation 1999; 67(1): 131.
16. + T cells. J Immunol 1999; 163(5): 2358.
17. + T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715.
18. Han WR, Zhan Y, Murray-Segal LJ, et al. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice. Transplantation 2000; 70(1): 168.
19. + T cells can trigger allograft rejection. J Immunol 2000; 165(2): 1111.
20. + cells and CD40-CD40 ligand interactions. J Immunol 2001; 166(5): 3248.
21. + T cells: there's more to it than MHC restriction. Am J Transplant 2003; 3(2): 107.
22. Le Moine A, Goldman M. Non-classical pathways of cell-mediated allograft rejection: new challenges for tolerance induction? Am J Transplant 2003; 3(2): 101.
23. Kirk AD. Location, location, location: regional immune mechanisms critically influence rejection. Nat Med 2002; 8(6): 553.
24. Lakkis FG. Where is the alloimmune response initiated? Am J Transplant 2003; 3(3): 241.
25. Sacks SH, Zhou W. Locally produced complement and its role in renal allograft rejection. Am J Transplant 2003; 3(8): 927.
26. Bumgardner GL, Heininger M, Li J, et al. A functional model of hepatocyte transplantation for in vivo immunologic studies. Transplantation 1998; 65(1): 53.
27. Seglen PO. Preparation of rat liver parenchymal cells: enzymatic requirements for tissue dispersion. Exp Cell Res 1973; 82: 391.
28. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13: 30.
29. Bumgardner GL, Orosz CG. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Immunol Rev 2000; 174: 260.
30. Wang Y, Gao D, Lunsford KE, et al. Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection. Am J Transplant 2003; 3(10): 1251.
31. + T cells in the development of allospecific cytotoxicity in hepatocyte sponge matrix allografts. Transplantation 1992; 53(4): 857.
32. Rossini AA, Mordes JP, Markees TG, et al. Induction of islet transplantation tolerance using donor specific transfusion and anti-CD154 monoclonal antibody. Transplant Proc 31(1-2): 629, 1999.
33. + T cells in allograft acceptance induced by DST and CD40/CD40L costimulatory blockade. Am J Transplant 2004; 4: 1061.
34. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A 1995; 92: 9560.
35. + T cell-mediated rejection of pancreatic islet allografts. J Immunol 2000; 165: 247.
36. Han D, Xu X, Pastori RL, et al. Elevation of cytotoxic lymphocyte gene expression is predictive of islet allograft rejection in nonhuman primates. Diabetes 2002; 51(3): 562.
37. + T lymphocytes. J Immunol 1993; 151(11): 5993.
38. + T cells: CD4-independent help. J Immunol 2001; 167(3): 1283.
39. Mintern JD, Davey GM, Belz GT, et al. Cutting edge: precursor frequency affects the helper dependence of cytotoxic T cells. J Immunol 2002; 168(3): 977.
40. + T cell response depending on the route of immunization. J Immunol 1998; 160(11): 5522.
41. Nicolls MR, Coulombe M, Yang H, et al. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4. J Immunol 2000; 164: 3627.
42. k strains of mice. Immunogenetics 1985; 22(6): 585.
43. Sun J, Sheil AG, Wang C, et al. Tolerance to rat liver allografts. IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes. Transplantation 1996; 62(12): 1725.
44. + T cells. J Exp Med 2002; 196(7): 877.
45. Haque MA, Mizobuchi T, Yasufuku K, et al. Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002; 169(3): 1542.
46. Rolls HK, Kishimoto K, Dong VM, et al. T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection. Transplantation 2002; 74(7): 1053.
47. Jackman SH, Boyse EA, Goldberg EH. Adoptive transfer of skin-selective autoimmunity induced by Skn alloantigenic disparities. Proc Natl Acad Sci U S A 1992; 89(22): 11041.
48. Baker MS, Chen X, Rotramel A, et al. Proinflammatory cytokines induce NF-kappaB-dependent/NO-independent chemokine gene expression in MIN6 beta cells. J Surg Res 2003; 110(1): 295.
49. Wang H, Gao X, Fukumoto S, et al. Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes. J Cell Physiol 1999; 181(2): 361.
50. Park JW, Gruys ME, McCormick K, et al. Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2). J Immunol 2001; 166(6): 3763.